The Division of Cardiology at the University of North Carolina at Chapel Hill is committed to the highest standards of excellence in the diagnosis and treatment of cardiovascular diseases. We are a multidisciplinary health care team offering state-of-the-art treatment and care to people of North Carolina and to those throughout the Southeast.

Experience, expertise and patient satisfaction are cornerstones of the patient care provided by the Division of Cardiology. We care for thousands of patients, both in clinic and in the hospital, each year and perform state-of-the-art procedures each year. We offer numerous specialty clinics (e.g., cardiovascular genetics, adults with congenital heart disease, lipid clinic, heart failure, electrophysiology, structural heart, interventional cardiology, hypertension, etc.) and run one of the largest cardiac rehabilitation programs in the state.

Our physicians and medical professionals expand the boundaries of cardiac care through


 Cardiology Grand Rounds & Events

There are no upcoming events at this time.


Cardiology News

  • Travel Award for Cardiology Fellow

    Sameer Arora, MD, a Cardiovascular Disease Fellow currently pursuing an MPH in Epidemiology, has been chosen for the Department of Epidemiology Travel Award by the UNC Gillings School of Public Health for his work investigating the epidemiology and current management patterns of ST-Elevation Myocardial Infarction in India. He is scheduled to travel to India later … Continued

  • New Research from Qian Lab, McAllister Heart Institute

    A McAllister team from Li Qian’s Lab has published new research in Cell Stem Cell that holds promise to “mend a broken heart” by describing how to directly reprogram human fibroblasts into cardiomyocytes.  The research described in the paper, “Single Cell Transcriptomic Analyses of Cell Fate Transitions during Human Cardiac Reprogramming”, is the first to … Continued

  • New JACC review paper for Cardiology Fellow Sameer Arora

    Cardiology fellow Sameer Arora has a new review in the Journal of the American College of Cardiology. The paper, “Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD,” shows that premature discontinuation of ticagrelor, a cornerstone of modern antithrombotic therapy, is common and is associated with adverse events.

More Cardiology News

Cardiology News on UNC Health Care